Explore the categories so you can find more about your search.

Categorie > Arthritis

Researchers Uncover New Piece To The Puzzle Of Human Height

Categorie : Arthritis
In studies involving more than 35,000 people and a survey across the entire human genome, an international team supported in part by the National Institutes of Health (NIH) has found evidence that common genetic variants recently linked to osteoarthritis may also play a minor role in human height. T ...

read more In studies involving more than 35,000 people and a survey across the entire human genome, an international team supported in part by the National Institutes of Health (NIH) has found evidence that common genetic variants recently linked to osteoarthritis may also play a minor role in human height. T read more Tue Jan 2008 Tue Jan 2008

Genetic Connection Found Between Short Stature And Arthritis

Categorie : Arthritis
Common genetic variants linked to arthritis may also play a role in human height, a new study shows.The international study was co-led by the University of Michigan School of Public Health. The journal Nature Genetics published the findings online Jan. 13.The new study confirms observations by healt ...

read more Common genetic variants linked to arthritis may also play a role in human height, a new study shows.The international study was co-led by the University of Michigan School of Public Health. The journal Nature Genetics published the findings online Jan. 13.The new study confirms observations by healt read more Mon Jan 2008 Mon Jan 2008

Rigel Announces Initiation Of Phase 1 Clinical Trial Of R348 For Rheumatoid Arthritis, Psoriasis And Other Immune Disorders

Categorie : Arthritis
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that it has begun enrolling patients in a Phase 1 study to evaluate the safety and tolerability of R348, an orally available, potent inhibitor of Janus Kinase 3 (JAK3), as a potential treatment for patients with rheumatoid arthritis (RA), psorias ...

read more Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that it has begun enrolling patients in a Phase 1 study to evaluate the safety and tolerability of R348, an orally available, potent inhibitor of Janus Kinase 3 (JAK3), as a potential treatment for patients with rheumatoid arthritis (RA), psorias read more Mon Jan 2008 Mon Jan 2008

Arthritis Patients See Improvement In Symptoms Following Exercise Program

Categorie : Arthritis
Patients with arthritis, the country's leading cause of disability, tend to be less fit than their peers who don't have this condition. Studies have shown, however, that they can safely participate in exercise programs to increase their fitness, strength and psychosocial status and that health provi ...

read more Patients with arthritis, the country's leading cause of disability, tend to be less fit than their peers who don't have this condition. Studies have shown, however, that they can safely participate in exercise programs to increase their fitness, strength and psychosocial status and that health provi read more Mon Jan 2008 Mon Jan 2008

Osteoarthritis Risk Linked To Finger Length Ratio

Categorie : Arthritis
People whose index finger is shorter than their ring finger are at higher risk of osteoarthritis, a new University of Nottingham study has found. A study of more than 2,000 people, published in the journal Arthritis and Rheumatism, suggests that people whose index finger is shorter than their rin ...

read more People whose index finger is shorter than their ring finger are at higher risk of osteoarthritis, a new University of Nottingham study has found. A study of more than 2,000 people, published in the journal Arthritis and Rheumatism, suggests that people whose index finger is shorter than their rin read more Mon Jan 2008 Mon Jan 2008

Breakthrough Offers Potential Treatment For Rheumatoid Arthritis

Categorie : Arthritis
A breakthrough in understanding the way atoms move across cell membranes in the human body could pave the way for the development of new treatments for inflammatory diseases such as rheumatoid arthritis.Scientists at the University of Leeds have identified a previously unknown natural mechanism that ...

read more A breakthrough in understanding the way atoms move across cell membranes in the human body could pave the way for the development of new treatments for inflammatory diseases such as rheumatoid arthritis.Scientists at the University of Leeds have identified a previously unknown natural mechanism that read more Mon Jan 2008 Mon Jan 2008

Large And Growing Public Health Problem Identified: The Prevalence And Impact Of Arthritis And Other Rheumatic Conditions

Categorie : Arthritis
Arthritis is the most common cause of disability in the United States. Over the next 25 years as the Baby Boom generation continues to age, the toll of this disease will escalate. To have a clear picture of the looming disease burden and its impact on our nation's health care and public health syste ...

read more Arthritis is the most common cause of disability in the United States. Over the next 25 years as the Baby Boom generation continues to age, the toll of this disease will escalate. To have a clear picture of the looming disease burden and its impact on our nation's health care and public health syste read more Mon Jan 2008 Mon Jan 2008

Independent Risk For Knee Osteoarthritis Linked To Index-To-Ring-Finger Length Ratio

Categorie : Arthritis
Index to ring finger length ratio (2D:4D) is a trait known for its sexual differences. Men typically have shorter second than fourth digits; in women, these fingers tend to be about equal in length. Smaller 2D:4D ratios have intriguing hormonal connections, including higher prenatal testosterone lev ...

read more Index to ring finger length ratio (2D:4D) is a trait known for its sexual differences. Men typically have shorter second than fourth digits; in women, these fingers tend to be about equal in length. Smaller 2D:4D ratios have intriguing hormonal connections, including higher prenatal testosterone lev read more Mon Jan 2008 Mon Jan 2008

Arthritis Burden Soaring, Experts Say

Categorie : Arthritis
Arthritis is exploding in an aging population of U.S. baby boomers and is projected to increase by 40% in the next two decades, according to a new study released by the Centers for Disease Control and Prevention (CDC) for the National Arthritis Data Workgroup. The report reaffirms that nearly one i ...

read more Arthritis is exploding in an aging population of U.S. baby boomers and is projected to increase by 40% in the next two decades, according to a new study released by the Centers for Disease Control and Prevention (CDC) for the National Arthritis Data Workgroup. The report reaffirms that nearly one i read more Mon Jan 2008 Mon Jan 2008

Does Weather Affect Arthritis Pain?

Categorie : Arthritis
With the winter weather biting hard in many parts of the country, you may be one of the many arthritis sufferers who feel that their arthritis pain is influenced by the weather -- specifically, that they experience more arthritis pain on cold, rainy days and less arthritis pain on warm, dry days.Joh ...

read more With the winter weather biting hard in many parts of the country, you may be one of the many arthritis sufferers who feel that their arthritis pain is influenced by the weather -- specifically, that they experience more arthritis pain on cold, rainy days and less arthritis pain on warm, dry days.Joh read more Mon Jan 2008 Mon Jan 2008

MorphoSys Files Clinical Trial Application To Initiate First Phase 1 Clinical Study Of Its MOR103 Program For Rheumatoid Arthritis Treatment

Categorie : Arthritis
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that it has submitted a clinical trial application (CTA) to initiate a phase 1 trial using the HuCAL-derived antibody MOR103 for the treatment of Rheumatoid Arthritis. MorphoSys plans to reveal the target molecule of its lead an ...

read more MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that it has submitted a clinical trial application (CTA) to initiate a phase 1 trial using the HuCAL-derived antibody MOR103 for the treatment of Rheumatoid Arthritis. MorphoSys plans to reveal the target molecule of its lead an read more Mon Dec 2007 Mon Dec 2007

ScienceDirect To Host French-Language Journals From Elsevier Masson

Categorie : Arthritis
Elsevier, a leading publisher of scientific, technical and medical (STM) information, has announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.The titles, including Feuillets de Radiologie, Journal de Chirurgie and La Pr ...

read more Elsevier, a leading publisher of scientific, technical and medical (STM) information, has announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.The titles, including Feuillets de Radiologie, Journal de Chirurgie and La Pr read more Fri Dec 2007 Fri Dec 2007

NicOx Completes Enrollment In Second Pivotal Phase 3 Study For Naproxcinod And Provides Development Update

Categorie : Arthritis
NicOx S.A. (Eurolist: COX) announced it has successfully completed the enrollment of 1020 patients in the 302 pivotal phase 3 study for naproxcinod, in-line with projections. Naproxcinod is the Company's lead investigational drug product and the first compound in the COX-Inhibiting Nitric Oxide-Don ...

read more NicOx S.A. (Eurolist: COX) announced it has successfully completed the enrollment of 1020 patients in the 302 pivotal phase 3 study for naproxcinod, in-line with projections. Naproxcinod is the Company's lead investigational drug product and the first compound in the COX-Inhibiting Nitric Oxide-Don read more Fri Dec 2007 Fri Dec 2007

EntreMed Announces FDA Acceptance Of IND Application For Panzem(R) In Rheumatoid Arthritis

Categorie : Arthritis
EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for Panzem(R) (2-Methoxyestrad ...

read more EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for Panzem(R) (2-Methoxyestrad read more Wed Dec 2007 Wed Dec 2007

Studies Show Effectiveness Of EUFLEXXA(TM) In Treating Knee Osteoarthritis And Reducing The Pain That Interferes With Daily Activities

Categorie : Arthritis
Ferring Pharmaceuticalspresented the results of two studies on the effectiveness of EUFLEXXA(TM),an intra-articular hyaluronic acid (IA-HA) for the relief of pain in kneeosteoarthritis (OA), at the Osteoarthritis Research Society International'sWorld Congress on Osteoarthritis 2007 in Ft. Lauderdale ...

read more Ferring Pharmaceuticalspresented the results of two studies on the effectiveness of EUFLEXXA(TM),an intra-articular hyaluronic acid (IA-HA) for the relief of pain in kneeosteoarthritis (OA), at the Osteoarthritis Research Society International'sWorld Congress on Osteoarthritis 2007 in Ft. Lauderdale read more Wed Dec 2007 Wed Dec 2007

New Study Uncovers Prevalence, Burden Of Pediatric Arthritis In U.S.

Categorie : Arthritis
A study published in the December issue of Arthritis Care & Research estimates that 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition. The study, conducted by the Centers for Disease Control and Prevention ...

read more A study published in the December issue of Arthritis Care & Research estimates that 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition. The study, conducted by the Centers for Disease Control and Prevention read more Wed Dec 2007 Wed Dec 2007

Arthritis Foundation Announces Amgen And Wyeth To Be Presenting Sponsor Of The 2008 Arthritis Walk(R)

Categorie : Arthritis
The Arthritis Foundation, the leading health organization addressing the needs of 46 million Americans living with arthritis, announced that Amgen and Wyeth Pharmaceuticals, co-marketers of EnbrelŪ (etanercept), will be the national presenting sponsor of the 2008 Arthritis WalkŪ. [click link for ful ...

read more The Arthritis Foundation, the leading health organization addressing the needs of 46 million Americans living with arthritis, announced that Amgen and Wyeth Pharmaceuticals, co-marketers of EnbrelŪ (etanercept), will be the national presenting sponsor of the 2008 Arthritis WalkŪ. [click link for ful read more Wed Dec 2007 Wed Dec 2007

Acologix Presents Preclinical Data On Cartilage Regeneration By AC-100 At The OARSI 2007 World Congress On Osteoarthritis

Categorie : Arthritis
Acologix, Inc., a privately held biopharmaceutical company, announced preclinical study results demonstrating that AC-100, its novel synthetic peptide derived from an endogenous human protein produced by bone and dental cells, promoted cartilage regeneration in an animal model. The data was presente ...

read more Acologix, Inc., a privately held biopharmaceutical company, announced preclinical study results demonstrating that AC-100, its novel synthetic peptide derived from an endogenous human protein produced by bone and dental cells, promoted cartilage regeneration in an animal model. The data was presente read more Sun Dec 2007 Sun Dec 2007

The Benefits Of Hip Replacement

Categorie : Arthritis
Total hip arthroplasty (THA), or hip replacement, is an effective treatment for osteoarthritis (OA), but most studies have only followed patients for up to one year. A new study published in the December issue of Arthritis Care & Research examined patients after an average of eight years following h ...

read more Total hip arthroplasty (THA), or hip replacement, is an effective treatment for osteoarthritis (OA), but most studies have only followed patients for up to one year. A new study published in the December issue of Arthritis Care & Research examined patients after an average of eight years following h read more Fri Dec 2007 Fri Dec 2007

Pine Bark Naturally Reduces Osteoarthritis Knee Pain

Categorie : Arthritis
Affecting more than 10 million Americans, Osteoarthritis of the knee (OA) is one of the five leading causes of disability among the elderly. While OA mainly affects most people over 45, it can occur at any age. A double-blind, placebo-controlled study published in the journal Nutrition Research reve ...

read more Affecting more than 10 million Americans, Osteoarthritis of the knee (OA) is one of the five leading causes of disability among the elderly. While OA mainly affects most people over 45, it can occur at any age. A double-blind, placebo-controlled study published in the journal Nutrition Research reve read more Fri Dec 2007 Fri Dec 2007

<<< previous | 4 | 5 | 6 | 7 | 8 | 9 | 10 next >>>



     


Custom Search